MwanzoHLUN-A • CPH
add
H. Lundbeck A/S Class A
Bei iliyotangulia
kr 36.00
Bei za siku
kr 35.65 - kr 36.20
Bei za mwaka
kr 27.10 - kr 41.70
Thamani ya kampuni katika soko
42.19B DKK
Wastani wa hisa zilizouzwa
elfu 58.40
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
CPH
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(DKK) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 5.72B | 15.55% |
Matumizi ya uendeshaji wa biashara | 3.67B | 23.76% |
Mapato halisi | 777.00M | 14.94% |
Kiwango cha faida halisi | 13.58 | -0.51% |
Mapato kwa kila hisa | 1.30 | 11.11% |
EBITDA | 1.43B | 3.10% |
Asilimia ya kodi ya mapato | -6.15% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(DKK) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 8.32B | 95.90% |
Jumla ya mali | 39.52B | 4.89% |
Jumla ya dhima | 15.68B | 2.04% |
Jumla ya hisa | 23.84B | — |
hisa zilizosalia | 996.15M | — |
Uwiano wa bei na thamani | 1.50 | — |
Faida inayotokana na mali | 6.11% | — |
Faida inayotokana mtaji | 8.67% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(DKK) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | 777.00M | 14.94% |
Pesa kutokana na shughuli | 2.30B | 54.50% |
Pesa kutokana na uwekezaji | -101.00M | -4.12% |
Pesa kutokana na ufadhili | -24.00M | 97.05% |
Mabadiliko halisi ya pesa taslimu | 2.17B | 270.77% |
Mtiririko huru wa pesa | 985.25M | -28.86% |
Kuhusu
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
14 Ago 1915
Tovuti
Wafanyakazi
5,500